A detailed history of Foster & Motley Inc transactions in Viatris Inc stock. As of the latest transaction made, Foster & Motley Inc holds 47,656 shares of VTRS stock, worth $601,418. This represents 0.04% of its overall portfolio holdings.

Number of Shares
47,656
Previous 46,799 1.83%
Holding current value
$601,418
Previous $497,000 11.27%
% of portfolio
0.04%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$10.32 - $12.13 $8,844 - $10,395
857 Added 1.83%
47,656 $553,000
Q2 2024

Aug 02, 2024

SELL
$10.05 - $12.02 $160 - $192
-16 Reduced 0.03%
46,799 $497,000
Q1 2024

Apr 18, 2024

SELL
$11.27 - $13.53 $29,516 - $35,435
-2,619 Reduced 5.3%
46,815 $559,000
Q4 2023

Feb 01, 2024

BUY
$8.77 - $10.85 $145,187 - $179,621
16,555 Added 50.35%
49,434 $535,000
Q3 2023

Oct 24, 2023

BUY
$9.59 - $11.35 $155,290 - $183,790
16,193 Added 97.05%
32,879 $324,000
Q2 2023

Aug 08, 2023

SELL
$9.02 - $10.29 $23,776 - $27,124
-2,636 Reduced 13.64%
16,686 $167,000
Q1 2023

May 09, 2023

BUY
$9.2 - $12.26 $42,954 - $57,241
4,669 Added 31.86%
19,322 $186,000
Q4 2022

Feb 09, 2023

BUY
$8.72 - $11.56 $127,774 - $169,388
14,653 New
14,653 $163,000
Q1 2022

Apr 28, 2022

SELL
$9.81 - $15.4 $116,032 - $182,151
-11,828 Closed
0 $0
Q4 2021

Jan 25, 2022

SELL
$12.09 - $14.68 $51,455 - $62,478
-4,256 Reduced 26.46%
11,828 $160,000
Q3 2021

Oct 29, 2021

SELL
$13.25 - $15.13 $11,275 - $12,875
-851 Reduced 5.03%
16,084 $218,000
Q2 2021

Jul 20, 2021

SELL
$12.97 - $16.15 $355,183 - $442,267
-27,385 Reduced 61.79%
16,935 $242,000
Q1 2021

Apr 26, 2021

SELL
$13.59 - $18.54 $1 Million - $1.37 Million
-73,906 Reduced 62.51%
44,320 $619,000
Q4 2020

Feb 01, 2021

BUY
$14.3 - $18.74 $1.69 Million - $2.22 Million
118,226 New
118,226 $2.22 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.